tiprankstipranks
Trending News
More News >
KalVista Pharmaceuticals (DE:4XC1)
FRANKFURT:4XC1
Germany Market

KalVista Pharmaceuticals (4XC1) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
16Bullish
3Neutral
3Bearish
Technical Analysis Consensus
Neutral
4Bullish
3Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
KalVista Pharmaceuticals’s (4XC1) Moving Averages Convergence Divergence (MACD) indicator is 0.20, suggesting KalVista Pharmaceuticals is a Sell.
KalVista Pharmaceuticals’s (4XC1) 20-Day exponential moving average is 13.12, while KalVista Pharmaceuticals’s (4XC1) share price is €13.5, making it a Buy.
KalVista Pharmaceuticals’s (4XC1) 50-Day exponential moving average is 12.86, while KalVista Pharmaceuticals’s (4XC1) share price is €13.5, making it a Buy.

KalVista Pharmaceuticals (4XC1) Pivot Points

Mar 12, 2026, 03:43 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
13.70
13.70
13.70
13.70
13.70
13.70
13.70
Fibonacci
13.70
13.70
13.70
13.70
13.70
13.70
13.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

KalVista Pharmaceuticals (4XC1) Moving Averages

Mar 12, 2026, 03:43 AM
Period
Simple
Exponential
MA5
13.46Buy
13.48Buy
MA10
13.29Buy
13.32Buy
MA20
12.95Buy
13.12Buy
MA50
12.98Buy
12.86Buy
MA100
12.13Buy
12.41Buy
MA200
11.68Buy
11.84Buy
KalVista Pharmaceuticals’s (4XC1) 10-Day exponential moving average is 13.32, while KalVista Pharmaceuticals’s (4XC1) share price is €13.5, making it a Buy.
KalVista Pharmaceuticals’s (4XC1) 100-Day exponential moving average is 12.41, while KalVista Pharmaceuticals’s (4XC1) share price is €13.5, making it a Buy.
KalVista Pharmaceuticals’s (4XC1) stock price is €13.5 and KalVista Pharmaceuticals’s (4XC1) 50-day simple moving average is 12.98, creating a Buy signal.
KalVista Pharmaceuticals’s (4XC1) stock price is €13.5 and KalVista Pharmaceuticals’s (4XC1) 100-day simple moving average is 12.13, creating a Buy signal.
KalVista Pharmaceuticals’s (4XC1) stock price is €13.5 and KalVista Pharmaceuticals’s (4XC1) 200-day simple moving average is 11.68, creating a Buy signal.

KalVista Pharmaceuticals (4XC1) Technical Indicators

Mar 12, 2026, 03:43 AM
Name
Value
Implied Action
RSI (14)
55.64
Neutral
STOCH (9,6)
83.33
Sell
STOCHRSI (14)
90.48
Sell
MACD (12,26)
0.20
Sell
ADX (14)
12.60
Buy
Williams %R
-21.43
Buy
CCI (14)
96.49
Neutral
ATR (14)
0.30
-
Ultimate Oscillator
63.25
Neutral
ROC
8.87
Buy
KalVista Pharmaceuticals’s (4XC1) Relative Strength Index (RSI) is 55.64, creating a Neutral signal.
KalVista Pharmaceuticals’s (4XC1) Trend Strength Indicator (ADX) is 12.60, creating a Buy signal.
KalVista Pharmaceuticals’s (4XC1) Commodity Channel Index (CCI) is 96.49, creating a Neutral signal.
KalVista Pharmaceuticals’s (4XC1) Price Rate of Change (ROC) is 8.87, creating a Buy signal.

FAQ

Is 4XC1 a Buy, Hold, or Sell?
Based on 4XC1’s technical indicators, 4XC1 is a Strong Buy.
    What is 4XC1’s RSI (14)?
    4XC1’s RSI (14) is 55.64, which suggests 4XC1 is a Neutral.
      What is 4XC1’s MACD?
      4XC1’s MACD is 0.20, which suggests 4XC1 is a Sell.
        What is 4XC1’s 5-day moving average?
        4XC1’s 5-day moving average is 13.46, which suggests 4XC1 is a Buy.
          What is 4XC1’s 20-day moving average?
          4XC1 20-day moving average is 12.95, which suggests 4XC1 is a Buy.
            What is 4XC1’s 50-day moving average?
            4XC1’s 50-day moving average is 12.98, which suggests 4XC1 is a Buy.
              What is 4XC1’s 200-day moving average?
              4XC1’s 200-day moving average is 11.68, which suggests 4XC1 is a Buy.
                What is 4XC1’s Williams % R (14)?
                4XC1’s Williams % R (14) is -21.43, which suggests 4XC1 is a Buy.
                  What is 4XC1’s CCI (14)?
                  4XC1’s CCI (14) is 96.49, which suggests 4XC1 is a Neutral.
                    What is the share price of KalVista Pharmaceuticals?